The Efficacy and Safety of Anti-epidermal Growth Factor Receptor Monoclonal Antibodies in Nasopharyngeal Carcinoma: Literature-based Meta-analyses

Background: Anti-epidermal growth factor receptor monoclonal antibodies (anti-EGFR mAbs), such as cetuximab and nimotuzumab have been used in the treatment of nasopharyngeal carcinoma (NPC), yet their efficacy and safety are undetermined. Materials and Methods: We performed two meta-analyses based o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Cancer
Main Authors: Peng, Liang, Liu, Ze-Long, Xu, Cheng, Tang, Ling-Long, Liu, Xu, Lin, Ai-Hua, Sun, Ying, Chen, Yu-Pei, Ma, Jun
Formato: Artigo
Idioma:Inglês
Publicado: Ivyspring International Publisher 2018
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6277641/
https://ncbi.nlm.nih.gov/pubmed/30519357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.27611
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares